Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.70 |
| ▸ | JAK3 | P52333 | 1/20 | 0.70 |
| ▸ | F13A1 | P00488 | 1/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | THPO | P40225 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30616852 | 1.00 | MAPT (1.00) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Bromide SCHEMBL28839154 | 0.98 | MAPT (0.97) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Potassium SCHEMBL29870134 | 0.98 | MAPT (0.97) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Water SCHEMBL1321161 | 0.98 | MAPT (0.97) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| SCHEMBL29870429 | 0.98 | MAPT (0.97) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Hydrochloric Acid SCHEMBL28839145 | 0.98 | MAPT (0.97) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Acetic Acid SCHEMBL28839867 | 0.97 | MAPT (0.93) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Phosphoric Acid SCHEMBL28952898 | 0.94 | MAPT (0.88) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Formic Acid SCHEMBL28839111 | 0.94 | MAPT (0.88) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| Sulfuric Acid SCHEMBL28839069 | 0.94 | MAPT (0.88) | MAPTKDM4EHSD17B10HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12403719-B2 | Efficient ink erasure system | SOCIéTé BIC (FR) | 2025-09-02 | — | — | US | claimed |
| CN-118294579-B | Method for identifying metabolites and non-target metabonomics combined supervision and study of Boea chenopodii honey | 中国农业科学院蜜蜂研究所 | 2025-02-18 | — | — | CN | claimed |
| CN-119265237-A | Method for improving silk performance by combining gene operation with in-vitro and in-vivo combined action of physicochemical treatment | 浙江超丝生物科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-118325376-A | Antimicrobial coating and preparation method and application thereof | 泛领生物医学技术(苏州)有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-20240227430-A1 | EFFICIENT INK ERASURE SYSTEM | SOCIéTé BIC (FR) | 2024-07-11 | — | — | US | claimed |
| CN-118294579-A | Method for identifying metabolites and non-target metabonomics combined supervision and study of Boea chenopodii honey | 中国农业科学院蜜蜂研究所 | 2024-07-05 | — | — | CN | claimed |
| CN-115290768-B | Method for detecting effective components of pediatric Qixing tea particles | 广州中医药大学(广州中医药研究院) | 2024-06-11 | — | — | CN | claimed |
| CN-115290769-B | Method for detecting effective components of pediatric Qixing tea particles | 广州中医药大学(广州中医药研究院) | 2024-05-14 | — | — | CN | claimed |
| EP-4330052-A1 | EFFICIENT INK ERASURE SYSTEM | Société BIC (FR) | 2024-03-06 | — | — | EP | claimed |
| CN-117304162-A | Novel cicada slough acetyldopamine trimer with anti-inflammatory activity and preparation method and application thereof | 江苏省中医药研究院 | 2023-12-29 | — | — | CN | claimed |
| US-20160090489-A1 | SURFACE TREATMENT COMPOSITON FOR FORMING SELF-ASSEMBLED COATING CAPABLE OF BEING EASILY COATED, REMOVED OR RECOATED | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2016-03-31 | — | — | US | claimed |
| CN-102285958-A | Dopamine polymer as well as derivative, preparation method and medicinal purpose thereof | — | 2011-12-21 | — | — | CN | claimed |
| US-20080234385-A1 | N-acetyl dopamine derivatives or N-alkyldopamine derivatives and a pharmaceutically acceptable carrier for treating a cell, preferably in an animal or human suffering from overexpression or abundant TNF-alpha | CARITAS ST. ELIZABETH'S MEDICAL CENTER (US) | 2008-09-25 | — | — | US | claimed |
| US-20080200557-A1 | Method for Inhibiting Lipid Peroxidation | CARITAS ST. ELIZABETH HOSPITAL OF BOSTON, INC. (US) | 2008-08-21 | — | — | US | claimed |
| WO-2007016214-A2 | METHOD FOR INHIBITING TNF-ALPHA | CARITAS ST. ELIZABETH'S MEDICAL CENTER (US) | 2007-02-08 | — | — | WO | claimed |
| WO-2006014507-A2 | METHOD FOR INHIBITING LIPID PEROXIDATION | CARITAS ST. ELIZABETH HOSPITAL OF BOSTON, INC. (US) | 2006-02-09 | — | — | WO | claimed |
| US-20040261198-A1 | Restructuring and finishing of keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-30 | — | — | US | claimed |
| EP-1477165-A2 | Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis | Cornell Research Foundation, INC. (US) | 2004-11-17 | — | — | EP | claimed |
| US-4453941-A | Composition and process for producing pigmentation in hair or skin | BOARD OF OVERSEERS OF GOSHEN COLLEGE (US) | 1984-06-12 | — | — | US | claimed |
| US-4390341-A | Composition and process for producing pigmentation in hair or skin | BOARD OF OVERSEERS OF GOSHEN COLLEGE (US) | 1983-06-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200557-A1 | Method for Inhibiting Lipid Peroxidation | AANAT, LPO, GPX4 | MAPT 3653/4885KDM4E 4727/4885HSD17B10 231/4885 |
| US-20080234385-A1 | N-acetyl dopamine derivatives or N-alkyldopamine derivatives and a pharmaceutically acceptable carrier for treating a cell, preferably in an animal or human suffering from overexpression or abundant TNF-alpha | AANAT, TNF, SLC6A3 | MAPT 1888/4885KDM4E 4780/4885HSD17B10 1444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.